Last reviewed · How we verify
placebo for rizankizumab
Placebo is an inert substance with no active pharmacological mechanism.
At a glance
| Generic name | placebo for rizankizumab |
|---|---|
| Sponsor | AbbVie |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo serves as a control comparator in clinical trials and contains no active pharmaceutical ingredient. It is used to establish the baseline efficacy and safety profile of the active drug (rizankizumab) by comparison. Any observed effects are attributed to natural disease progression, regression to the mean, or the placebo effect rather than direct drug action.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |